JP2006514110A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514110A5
JP2006514110A5 JP2005506646A JP2005506646A JP2006514110A5 JP 2006514110 A5 JP2006514110 A5 JP 2006514110A5 JP 2005506646 A JP2005506646 A JP 2005506646A JP 2005506646 A JP2005506646 A JP 2005506646A JP 2006514110 A5 JP2006514110 A5 JP 2006514110A5
Authority
JP
Japan
Prior art keywords
phenyl
substituted
alkyl
alkoxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005506646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/011976 external-priority patent/WO2004043926A1/en
Publication of JP2006514110A publication Critical patent/JP2006514110A/ja
Publication of JP2006514110A5 publication Critical patent/JP2006514110A5/ja
Pending legal-status Critical Current

Links

JP2005506646A 2002-11-11 2003-10-29 Ip受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体 Pending JP2006514110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02025024 2002-11-11
EP03011397 2003-05-20
PCT/EP2003/011976 WO2004043926A1 (en) 2002-11-11 2003-10-29 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist

Publications (2)

Publication Number Publication Date
JP2006514110A JP2006514110A (ja) 2006-04-27
JP2006514110A5 true JP2006514110A5 (https=) 2006-12-07

Family

ID=32313830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005506646A Pending JP2006514110A (ja) 2002-11-11 2003-10-29 Ip受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体

Country Status (19)

Country Link
US (1) US20060089371A1 (https=)
EP (1) EP1575919A1 (https=)
JP (1) JP2006514110A (https=)
KR (1) KR20050074571A (https=)
AR (1) AR042023A1 (https=)
AU (1) AU2003276201A1 (https=)
BR (1) BR0316191A (https=)
CA (1) CA2505361A1 (https=)
CO (1) CO5580824A2 (https=)
EC (1) ECSP055789A (https=)
HN (1) HN2003000353A (https=)
HR (1) HRP20050529A2 (https=)
MA (1) MA27491A1 (https=)
NO (1) NO20052797D0 (https=)
PE (1) PE20040672A1 (https=)
PL (1) PL376993A1 (https=)
TW (1) TW200418799A (https=)
UY (1) UY28072A1 (https=)
WO (1) WO2004043926A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1243262T3 (da) 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
ES2185606T3 (es) 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
JP4664924B2 (ja) 2003-12-02 2011-04-06 ウーツェーベー ファルマ ゲーエムベーハー 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用
CA2545422C (en) * 2003-12-03 2015-06-02 Cytopia Research Pty Ltd Tubulin inhibitors
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
PL1781276T3 (pl) 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
WO2006029735A1 (en) * 2004-09-15 2006-03-23 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with prostaglandin 12 receptor (ptgir)
GT200500284A (es) * 2004-10-15 2006-03-27 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
PE20070404A1 (es) * 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
AU2006275403A1 (en) 2005-08-02 2007-02-08 Lexicon Pharmaceuticals, Inc. 2-aminoaryl pyridines as protein kinases inhibitors
WO2007144195A2 (en) 2006-06-15 2007-12-21 Schwarz Pharma Ag Pharmaceutical composition with synergistic anticonvulsant effect
US20080242694A1 (en) * 2006-09-18 2008-10-02 D Sidocky Neil R Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
WO2009132310A1 (en) 2008-04-25 2009-10-29 Wisconsin Alumni Research Foundation Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
US20100060985A1 (en) 2008-09-09 2010-03-11 Fujifilm Corporation Method for producing polarizing plate, and automobile's windshield
US8536185B2 (en) 2008-09-22 2013-09-17 Cayman Chemical Company, Incorporated Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
CN105102448B (zh) 2013-02-28 2018-03-06 百时美施贵宝公司 作为rock1和rock2抑制剂的苯基吡唑衍生物
DK3013813T3 (da) 2013-06-27 2019-06-03 Pfizer Heteroaromatiske forbindelser og anvendelse deraf som dopamin-d1-ligander
US9828393B2 (en) * 2013-07-22 2017-11-28 The Regents Of The University Of Colorado, A Body Corporate Silylalkyloxyaryl compounds and methods for treating cancer
WO2016057338A1 (en) 2014-10-06 2016-04-14 Takeda Pharmaceutical Company Limited Heteroarylamide inhibitors of tbk1
US10080757B2 (en) 2016-03-11 2018-09-25 Wisconsin Alumni Research Foundation Inhibitors of UDP-galactopyranose mutase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259489A (en) * 1977-12-22 1981-03-31 Kyowa Gas Chemical Industry Co. Ltd. 2,3-Dicyanopyrazines
WO1996033972A1 (en) * 1995-04-28 1996-10-31 Glaxo Group Limited Methods for synthesizing diverse collections of pyridines, pyrimidines, 1,4-dihydro derivatives thereof, and piperidine derivatives
HUP0001232A3 (en) * 1996-12-23 2001-02-28 Elan Pharmaceuticals Inc San F Cycloalkyl, lactam, lactone derivatives and their thio analogues inhibiting betha-amyloid peptide release and/or its synthesis and pharmaceutical compositions containing the compounds
GB2323842A (en) * 1997-04-04 1998-10-07 Ferring Bv Pyridine derivatives
AU2623900A (en) * 1999-01-22 2000-08-07 American Home Products Corporation Compounds which inhibit leukocyte adhesion mediated by vla-4
US20020058606A1 (en) * 1999-05-10 2002-05-16 Gonzalez Maria Isabel Treatment of sexual dysfunction
KR100523119B1 (ko) * 2000-03-16 2005-10-20 에프. 호프만-라 로슈 아게 Ip 길항제로서의 카복실산 유도체
AU2002223802A1 (en) * 2000-11-17 2002-05-27 Warner-Lambert Company Llc Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
WO2002096933A1 (en) * 2001-05-30 2002-12-05 Novartis Ag 2-{[n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives

Similar Documents

Publication Publication Date Title
JP2006514110A5 (https=)
RU2485114C2 (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
RU2451674C2 (ru) Пиридинкарбоксамиды в качестве ингибиторов 11-бета-hsd1
RU2499795C2 (ru) Антагонисты гистаминовых н3-рецепторов
JP2004521087A5 (https=)
JP2013517283A5 (https=)
RU2006131304A (ru) Производные имидазо[1,2-c]пиримидинилуксусной кислоты
JP2006524645A5 (https=)
RU2007140735A (ru) Производные пиридин-3-карбоксамида в качестве обратных агонистов св1
JP2005538955A5 (https=)
JP2004517925A5 (https=)
HUP0401950A2 (hu) Pirimidin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
JP2006509748A5 (https=)
RU2012126987A (ru) Спироиндолциклопропаниндолиноны в качестве модуляторов амрк
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
JP2020506946A5 (https=)
JP2005533827A5 (https=)
RU2004135064A (ru) Новые замещенные индолы
JP2011502958A5 (https=)
RU2008117329A (ru) Производные имидазопиридина как антагонисты аденозинового рецептора а2в
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2010509391A5 (https=)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
CA2504907A1 (en) Indoles useful in the treatment of androgen-receptor related diseases